Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for interleukin-2 receptor
Most Correlated Studies
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Drug target sets for approved compounds
Most Relevant Literature
- Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha …
- Distinct use of super-enhancer elements controls cell type-specific CD25 transcription and function.
- Liver Injury and Elevated Levels of Interleukins, Interleukin-2 Receptor, and Interleukin-6 Predict …
- Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
- Non-IL-2-blocking anti-CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic ef…
Most Relevant Clinical Trials
- Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb…
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Be…
- Safety and Efficacy Study of Immunotherapy With Rituximab and Interleukin-2 in Patients With Non-Hod…
- Treatment With Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients With Le…
- Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides
